title: Surgical outcomes and complications of Tube® (Promedon) malleable penile prostheses in diabetic versus non-diabetic patients with erectile dysfunction.
abstract: OBJECTIVE
  To evaluate surgical outcome, complications, and patients satisfaction with the Tube® (Promedon, Cordoba, Argentina) malleable penile prosthesis in diabetic and non-diabetic patients with refractory erectile dysfunction (ED).
  
  
  METHODS
  The records of 128 eligible patients who received Tube malleable penile prostheses at our institute between September 2008 and October 2015 were reviewed.
  
  
  RESULTS
  Of the 128 patients, who received Tube penile prostheses at our institute, 53 were diabetics and 75 were non-diabetics. Both groups of patients were comparable for mean age, education level, marital status, hospital stay, time to commencing sexual intercourse, and median follow-up. Complications included: inter-corporeal septal perforation (2.3%), glanular urethral injury (1.5%), acute urinary retention (3.9%), superficial wound infection (7%), penile discomfort (9.4%), and penile prostheses infection (5.5%). Moreover, 3.9% developed atrophy of the cavernosal tissue, 5.5% experienced bad cosmesis, 6.3% experienced ejaculatory disorders, and 2.3% developed bladder calculi. In all, 13 prostheses (9.4%) were removed, seven of them due to infection, three on the patients' demand and three due to mechanical failure. The satisfaction rates with the prostheses were 77.3% and 79.4% in the diabetic and non-diabetic patients, respectively; with an overall satisfaction rate of 78.5%. There was no significant difference in the complication rate or prostheses infection between diabetic and non-diabetic patients.
  
  
  CONCLUSIONS
  Tube malleable penile prostheses are associated with low complication and high satisfaction rates. There was no significant difference in the complication rate or prostheses infection between diabetic and non-diabetic patients. A prospective comparative study with a large number of patients is recommended.
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Elnisr Rashed
authors.initials: ER
authors.lastname: Mohamed
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Ahmed Rashed
authors.initials: AR
authors.lastname: Hammady
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Mohamed Zaki
authors.initials: MZ
authors.lastname: Eldahshoury
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Ahmed Mamdouh
authors.initials: AM
authors.lastname: Elsharkawi
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Ahmed Mahmoud
authors.initials: AM
authors.lastname: Riad
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Hazem Mohamed
authors.initials: HM
authors.lastname: Elmogazy
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Mohamed Mostafa
authors.initials: MM
authors.lastname: Hussien
authors.affiliation: Urology Department, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Wael Mohamed
authors.initials: WM
authors.lastname: Gamal
keywords: DM, diabetes mellitus; Diabetic patients; ED, erectile dysfunction; Erectile dysfunction; Malleable prostheses; NO, nitric oxide; Outcome; PDE5I, phosphodiesterase type 5 inhibitor; PGE1, prostaglandin E1; US, ultrasonography; cGMP, cyclic guanosine monophosphate